![Storme Moore-Thornicroft](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storme Moore-Thornicroft
Fondatore presso Emergex Vaccines Holding Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Thomas Rademacher | M | - |
Emergex Vaccines Holding Ltd.
![]() Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | 8 anni |
Finian Tan | M | - |
Emergex Vaccines Holding Ltd.
![]() Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | - |
Michael D. Vaughan Rake | M | 76 |
Emergex Vaccines Holding Ltd.
![]() Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | 1 anni |
Sergio Pagani | M | - |
Emergex Vaccines Holding Ltd.
![]() Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | - |
Yi Xiang Dong | M | - |
Emergex Vaccines Holding Ltd.
![]() Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | - |
Mohan Philip | M | - |
Emergex Vaccines Holding Ltd.
![]() Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
David Clifford Jackson | M | 75 |
Emergex Vaccines Holding Ltd.
![]() Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | - |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 7 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Storme Moore-Thornicroft
- Contatti personali